Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$527.67 +1.48 (+0.28%)
At close: Sep 28, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Total Non-Current Liabilities (2009 - 2026)

Updated

Vertex Pharmaceuticals' Total Non-Current Liabilities came in at $5.92 billion for Q2 2026, up 4.4% from $5.67 billion a year earlier and up 0.8% from the prior quarter.

Analysis

Vertex Pharmaceuticals (VRTX) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

At the end of FY2025, Vertex Pharmaceuticals' Total Non-Current Liabilities was $5.71 billion, up 11.7% from FY2024.

  • Total Non-Current Liabilities has increased in each of the last eight years, with a five-year compound annual growth rate of 14.7% (FY2020 to FY2025).
  • Going back by year, Total Non-Current Liabilities was $5.11 billion in FY2024 (+19.6%), $4.27 billion in FY2023 (+20.3%), $3.55 billion in FY2022 (+17.3%) and $3.03 billion in FY2021 (+5.3%).
  • The five-year range for quarterly Total Non-Current Liabilities is $2.9 billion (Q3 2021) to $6.31 billion (Q3 2025).
  • Year-over-year, Total Non-Current Liabilities has increased for 34 consecutive quarters, with growth averaging 16.5% over the last eight quarters.
  • Across the past five years, year-over-year growth in Total Non-Current Liabilities ran from 4.4% in Q2 2026 to 30.7% in Q3 2024.
  • Business Quant data shows VRTX's Total Non-Current Liabilities at $5.87 billion (Q1 2026), $5.71 billion (Q4 2025) and $6.31 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 105.99 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 106.45 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -967.00 Mn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 5.92 Bn
10 Bristol Myers Squibb 128.45 Bn 79.72 Bn 9.25 Bn 60.97 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.92 Bn
Mar 31, 2026 5.87 Bn
Dec 31, 2025 5.71 Bn
Sep 30, 2025 6.31 Bn
Jun 30, 2025 5.67 Bn
Mar 31, 2025 5.43 Bn
Dec 31, 2024 5.11 Bn
Sep 30, 2024 5.68 Bn
Jun 30, 2024 4.48 Bn
Mar 31, 2024 4.52 Bn
Dec 31, 2023 4.27 Bn
Sep 30, 2023 4.34 Bn
Jun 30, 2023 4.12 Bn
Mar 31, 2023 3.82 Bn
Dec 31, 2022 3.55 Bn
Sep 30, 2022 3.55 Bn
Jun 30, 2022 3.52 Bn
Mar 31, 2022 3.17 Bn
Dec 31, 2021 3.03 Bn
Sep 30, 2021 2.90 Bn
API Access

Vertex Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=VRTX&period=max&api_key=YOUR_API_KEY